Dr Andy Chevigné, Group Leader of the Immuno-Pharmacology and Interactomics research group at the LIH Department of Infection and Immunity (DII), was rewarded for his outstanding contribution to the fields of allergology and molecular pharmacology through the bestowal of the “Prix du Fonds Léon et Henri Fredericq” by the Royal Academy of Science, Letters and Fine Arts of Belgium.
On December 22nd, the Academy announced the 2020 laureates of its Science Class. Namely, Dr Chevigné received the 2019 “Prix du Fonds Léon et Henri Fredericq” for his work on the elucidation of the mechanism of activation of major allergens in dust mites and the mode of activation and regulation of G protein-coupled receptors (GPCRs). GPCRs are the largest family of cellular membrane proteins and mediate most physiological responses to hormones, neurotransmitters and metabolites. They also play a crucial role in the orchestration of the migration of immune cells and have emerged as promising therapeutic targets for a broad spectrum of diseases, including inflammatory and autoimmune disorders but also for many cancers.
I am truly honoured and grateful to the jury for this recognition, which comes as an additional acknowledgement of the innovative and impactful work my team and I have been performing in the framework of LIH’s patient-centric and transversal research
Established in 1969, the “Prix du Fonds Léon et Henri Fredericq” is awarded to researchers having particularly distinguished themselves through original research in the field of physiology or related sciences, such as molecular biology, biochemistry, biophysics and pharmacodynamics.
Dr Andy ChevignéGroup Leader, Immuno-Pharmacology and Interactomics
Department of Infection and Immunity Luxembourg Institute of Health
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
5 months 27 days
This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
Analytical cookies are used to understand how visitors interact with the website. These cookies provide information on metrics such as number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
This cookie is installed by Google Analytics.
Set by Google to distinguish users.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.